POP-OUT | CLOSE
 
 
RITONAVIR
 
RIT is found in 13 entries
RIT
  •   Chemical Component Summary   Hide
    Name RITONAVIR
    Identifiers N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
    1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenyl-hexan-2-yl]carbamate
    Synonyms A-84538
    Formula C37 H48 N6 O5 S2
    Molecular Weight 720.94 g/mol
    Type peptide-like
    Isomeric SMILES
    InChI
    InChI key NCDNCNXCDXHOMX-XGKFQTDJSA-N
    Sub-components 013 015 VAL 019
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00503   (Stereoisomeric match)
    Name Ritonavir
    Groups approved
    Description An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. [PubChem]
    Synonyms Abbott 84538
    Brand names
    • Norvir
    • Norvir Sec
    Affected organism Human Immunodeficiency Virus
    Indication Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.
    Pharmacology Ritonavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Ritonavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.
    Mechanism of action Ritonavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.
    Route of administration Oral
    Categories
    • Anti-HIV Agents
    • HIV Protease Inhibitors
    ATC-Code J05AE03
    AHFS-Code 08:18.08.08
    CAS number 155213-67-5
    Targets
    Name Sequence search Pharmacological action Actions
    HIV-1 protease   Search  yes inhibitor
     
Ligand Image